New combo therapy aims to boost walking recovery after spinal cord injury
NCT ID NCT05217498
First seen Nov 01, 2025 · Last updated May 22, 2026 · Updated 26 times
Summary
This study tests whether a drug called istradefylline can improve walking gains from low-oxygen therapy in people with chronic, incomplete spinal cord injury. About 40 adults will receive the drug or a placebo before walking practice. The goal is to see if blocking adenosine helps the nervous system strengthen walking pathways.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINAL CORD INJURIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Spaulding Rehabilitation Hospital
Cambridge, Massachusetts, 02138, United States
Conditions
Explore the condition pages connected to this study.